 |
|
New genetic research into nicotine addiction shows promise for personalized treatment
September 18, 2007Whether a smoking-cessation drug will enable you to quit smoking may depend on your genes, according to new genotyping research from the Centre for Addiction and Mental Health (CAMH). The study, published in the September issue of the journal Biological Psychiatry, found that the enzyme known to metabolize both the smoking cessation drug bupropion and nicotine is highly genetically variable in all ethnicities and influences smoking cessation. This finding is a step toward being able to tailor smoking cessation treatment to individuals based on their unique genetic make-up.
"This first study identifies a very common genetic variant (present in anywhere from 25 to 50 percent of world populations) that appears to affect the outcome of smoking cessation treatment," said Rachel Tyndale, Section Head of Pharmacogenetics at CAMH and lead researcher on the study, adding that the results would have to be replicated.
Tyndale and colleagues performed genotyping on smokers for CYP2B6, a gene known to be highly variable and whose enzyme metabolizes bupropion, nicotine and serotonin. Participants were then provided with either placebo or bupropion treatment for ten weeks and followed up for 6 months.
The research project, supported by the Canadian Institutes of Health Research and the National Institute of Health, found that 45% of individuals with a specific variant of the gene benefited from bupropion treatment and maintained abstinence longer while doing poorly on placebo, with a 32.5% abstinent rate vs. 14.3%, respectively. In contrast, the 55% with a different variant of the gene (wild type variant) had good abstinences rates on placebo and gained no additional benefit from Bupropion, suggesting no benefit from treating these individuals with Bupropion. Of note, this group was able to quit smoking very well in the absence of an active drug (on placebo).
What percentage of people fall into the group that appeared to benefit" Previous studies have shown that 45%, 50% and 25% of White, African and Asian North Americans have the former specific variant form of the CYP2B6 gene.
The current study looked only at people of European ancestry, says Dr. Tyndale, but she and her colleagues have begun a similar study in African American smokers. They hypothesize that the variant form of the CYP2B6 gene will influence the effectiveness of bupropion treatment and ability to quit smoking in the same way in African Americans as in those of European descent.
Centre for Addiction and Mental Health
The research project, supported by the Canadian Institutes of Health Research and the National Institute of Health, found that 45% of individuals with a specific variant of the gene benefited from bupropion treatment and maintained abstinence longer while doing poorly on placebo, with a 32.5% abstinent rate vs. 14.3%, respectively. In contrast, the 55% with a different variant of the gene (wild type variant) had good abstinences rates on placebo and gained no additional benefit from Bupropion, suggesting no benefit from treating these individuals with Bupropion. Of note, this group was able to quit smoking very well in the absence of an active drug (on placebo).
What percentage of people fall into the group that appeared to benefit" Previous studies have shown that 45%, 50% and 25% of White, African and Asian North Americans have the former specific variant form of the CYP2B6 gene.
The current study looked only at people of European ancestry, says Dr. Tyndale, but she and her colleagues have begun a similar study in African American smokers. They hypothesize that the variant form of the CYP2B6 gene will influence the effectiveness of bupropion treatment and ability to quit smoking in the same way in African Americans as in those of European descent.
Centre for Addiction and Mental Health
Nicotine Addiction Current Events and Nicotine Addiction News RSSCrushing cigarettes in a virtual reality environment reduces tobacco addiction
Smokers who crushed computer-simulated cigarettes as part of a psychosocial treatment program in a virtual reality environment had significantly reduced nicotine dependence and higher rates of tobacco abstinence than smokers participating in the same program who grasped a computer-simulated ball.
New study expands the list of hazardous chemicals in smokeless tobacco
Attention all smokeless tobacco users! It's time to banish the comforting notion that snuff and chewing tobacco are safe because they don't burn and produce inhalable smoke like cigarettes.
Skin color clue to nicotine dependence
Higher concentrations of melanin -- the color pigment in skin and hair -- may be placing darker pigmented smokers at increased susceptibility to nicotine dependence and tobacco-related carcinogens than lighter skinned smokers, according to scientists.
Caltech researchers find tiny genetic change keeps nicotine from binding to muscle cells
A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor.
Penn research probes genetic underpinnings of nicotine addiction
A new study from the Abramson Cancer Center and Department of Psychiatry in the University of Pennsylvania School of Medicine shows that smokers who carry a particular version of a gene for an enzyme that regulates dopamine in the brain may suffer from concentration problems and other cognitive deficits when abstaining from nicotine - a problem that puts them at risk for relapse during attempts to quit smoking.
ADHD appears to increase level of nicotine dependence in smokers
Young people with ADHD are not only at increased risk of starting to smoke cigarettes, they also tend to become more seriously addicted to tobacco and more vulnerable to environmental factors such as having friends or parents who smoke, according to a study from Massachusetts General Hospital reseachers.
Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system
Genetically modifying a receptor found on the neurons that produce the neurotransmitter dopamine has given California Institute of Technology (Caltech) researchers a unique glimpse into the workings of the brain's dopamine system--as well as a new target for treating diseases that result from either too much or too little of this critical neurotransmitter.
K-State professor's research suggests that cigarettes' power may not be in nicotine itself
There may be a very good reason why coffee and cigarettes often seem to go hand in hand.
If your first cigarette gave you a buzz and you now smoke, a gene may be to blame
Anyone who has ever tried smoking probably remembers that first cigarette vividly. For some, it brought a wave of nausea or a nasty coughing fit. For others, those first puffs also came with a rush of pleasure or "buzz."
Research reveals why some smokers become addicted with their first cigarette
New research from The University of Western Ontario reveals how the brain processes the 'rewarding' and addictive properties of nicotine, providing a better understanding of why some people seemingly become hooked with their first smoke.
More Nicotine Addiction Current Events and Nicotine Addiction News Articles
 |
Hooked but Not Helpless: Kicking Nicotine Addiction by Patricia Allison (Author), Jack Yost (Author) This book treats smoking as a real addiction and not just a bad habit. It teaches smokers who want to quit how to work through their drug dependency step by step and equips them with an arsenal of self-defense skills to disarm their most intense cravings and begin to retrain their minds. Inspiring stories from nine ex-smokers tell how they struggled through withdrawal, learned to face new challenges, and coped with ordinary stress without smoking again. |
 |
Silent Killer - (Nicotine Addiction) Brick Casey (Primary Contributor) |
 |
Nicotine Addiction: Tobacco Tantrums DVD Starring: Artist Not Provided Everyday a teenager somewhere tries nicotine, whether it is to rebel, to fit in or to look "cool." But this experimentation could have dire consequences. Nicotine is one of the most addictive drugs available. Trying it, whatever the reasons, can lead to a lifetime of addiction. Find out the dangers of nicotine. Also discover strategies to quit if you are already addicted. |
 |
Zero Nicotine Anti-Smoking Patch by Eye Five The proprietary herbal formulation in ZERO NICOTINE Patch contains ingredients that act as natural substitutes for nicotine; thereby satisfying the bodys craving for this substance, without all the negative side effects of patches containing the actual drug, nicotine. The all-natural ingredients will make you crave fewer cigarettes each day. This gradual process allows you to quit with no withdrawal symptoms and requires less willpower and effort on your part. After analyzing many applicable studies and products currently sold on the market, we have developed a revolutionary formula, found in ZERO NICOTINE Patch, which offers smoking cessation in a very short period. Withdrawal symptoms will be milder due to the all-natural nicotine substitute, which helps you shake the nicotine habit... |
![Stop Smoking With Hypnosis [CD on Demand]](http://ecx.images-amazon.com/images/I/51AMMMjFqtL._SL160_.jpg) |
Stop Smoking With Hypnosis [CD on Demand] by Ph.D. Dr. Zubin J. Mistry Dr. Zubin Mistry will begin to direct your subconscious mind to simply eliminate the need for a cigarette. You will easily and permanently eliminate the urges and desires to reach for a cigarette the very first time you listen to your CD.Your hypnotic CD will leave you feeling completely at ease around others who smoke. You will experience the power of hypnosis first-hand knowing you have eliminated cigarettes from your lifestyle permanently.By listening to your CD often, you will experience a relaxed, smoke-free mindset throughout your day. You will feel comfortable in social settings knowing that cigarettes no longer dictate your behaviors or limit your social environments. Your hypnotic CD will assist you with maintaining control over your eating pattern while eliminating the need for... |
 |
Native Remedies Crave-Rx Drops for Reducing Nicotine Cravings (50ml) by Native Remedies Crave-Rx Drops is a 100% natural, safe, and effective herbal remedy to help the body maintain systemic and mood balance during and after nicotine withdrawal. Crave-Rx contains no nicotine and contains a unique combination of selected herbal ingredients which have been clinically proven to reduce nicotine cravings due to their balancing effect on the brain chemicals known to be associated with addiction. Crave-Rx Drops also contain herbs which will help to prevent the sugar cravings and compensatory overeating which often cause people to go back to cigarettes due to unwanted weight gain. Use Crave-Rx Drops to help to reduce the physical craving for nicotine; help to prevent depression, restlessness and anxiety often associated with nicotine withdrawal; stop sugar craving and compensatory... |
 |
Coffee & Cigarettes Starring: Roberto Benigni, Steven Wright, Joie Lee, Cinqu? Lee, Steve Buscemi Directed By: Jim Jarmusch Also With: Jim Jarmusch (Writer), Jason Kliot (Producer), Demetra J. MacBride (Producer), Rudd Simmons (Producer), Jim Stark (Producer), Birgit Staudt (Producer), Joana Vincente (Producer) |
 |
Nicotine Is a Drug: The Hidden Dangers of Addiction DVD by Clearvue "Expose the truth about nicotine, a highly addictive drug that wields incredible power over the user. " |
 |
This is Nicotine (Addiction) by Karen Farrington (Author) In this powerful and illuminating new series, a team of journalists was commissioned to analyze and comment on the major substances that are seen by society as addictive and ultimately bad for our health. |
|
Smokeless Tobacco Recovery Program: Recover from Nicotine Addiction [VHS] Starring: David C. Jones |
| © 2009 BrightSurf.com |